Sankala Group’s Merck MRK Stock Holding History

Sankala Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.7K	Hold	229	–	–	0.02%	288
2025 Q4	$28.4K	Buy	+229	New	+$21.5K	0.02%	281

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sankala Group's MRK Position: Q1 2026 in Review

Sankala Group held its Merck (MRK) position steady in Q1 2026 at 229 shares worth $27.7K. The position accounts for 0.02% of the portfolio, ranked #288.

Sankala Group first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. The position peaked at $28.4K in Q4 2025. 3,789 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Sankala Group held 229 shares of Merck worth $27.7K as of Q1 2026.
Sankala Group left its Merck share count unchanged in Q1 2026.
Merck made up 0.02% of Sankala Group's portfolio in Q1 2026, its #288 holding.
Sankala Group first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
Sankala Group's Merck position peaked at $28.4K in Q4 2025.
3,789 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.